-
1
-
-
0032145490
-
Macrophagic myofasciitis: An emerging entity
-
DOI 10.1016/S0140-6736(98)02326-5
-
Gherardi RK, Coquet M, Chérin P, Authier FJ, Laforêt P, Bélec L, Figarella-Branger D, Mussini JM, Pellissier JF, Fardeau M (1998) Macrophagic myofasciitis: an emerging entity. Lancet 352:347-352. doi:10.1016/S0140-6736(98)02326-5. (Pubitemid 28352197)
-
(1998)
Lancet
, vol.352
, Issue.9125
, pp. 347-352
-
-
Gherardi, R.K.1
Coquet, M.2
Cherin, P.3
Authier, F.-J.4
Laforet, P.5
Belec, L.6
Figarella-Branger, D.7
Mussini, J.-M.8
Pellissier, J.-F.9
Fardeau, M.10
-
2
-
-
0034841256
-
Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle
-
doi:10.1093/brain/124.9.1821
-
Gherardi RK, Coquet M, Cherin P, Belec L, Moretto P, Dreyfus PA, Pellissier JF, Chariot P, Authier FJ (2001) Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. Brain 124:1821-1831. doi:10.1093/brain/124.9.1821.
-
(2001)
Brain
, vol.124
, pp. 1821-1831
-
-
Gherardi, R.K.1
Coquet, M.2
Cherin, P.3
Belec, L.4
Moretto, P.5
Dreyfus, P.A.6
Pellissier, J.F.7
Chariot, P.8
Authier, F.J.9
-
3
-
-
0041861192
-
Macrophagic myofasciitis: Focal or systemic?
-
DOI 10.1016/S1297-319X(03)00093-9
-
Papo T (2003) Macrophagic myofasciitis: focal or systemic? Jt Bone Spine 70:242-245. doi:10.1016/S1297-319X(03)00093-9. (Pubitemid 37064577)
-
(2003)
Joint Bone Spine
, vol.70
, Issue.4
, pp. 242-245
-
-
Papo, T.1
-
4
-
-
0347993821
-
Aluminum inclusion macrophagic myofasciitis: A recently identified condition
-
DOI 10.1016/S0889-8561(03)00095-X
-
Gherardi RK, Authier FJ (2003) Aluminum inclusion macrophagic myofasciitis: a recently identified condition. Immunol Allergy Clin North Am 23:699-712. doi:10.1016/S0889-8561(03)00095-X. (Pubitemid 38030164)
-
(2003)
Immunology and Allergy Clinics of North America
, vol.23
, Issue.4
, pp. 699-712
-
-
Gherardi, R.K.1
Authier, F.-J.2
-
5
-
-
0032846187
-
Macrophagic myofasciitis: Improvement with antibiotic therapy
-
Chérin P, Gherardi RK, Pennaforte JL (1999) Macrophagic myofasciitis: improvement with antibiotic therapy. J Rheumatol 26:2286-2287.
-
(1999)
J Rheumatol
, vol.26
, pp. 2286-2287
-
-
Chérin, P.1
Gherardi, R.K.2
Pennaforte, J.L.3
-
6
-
-
0034207655
-
Macrophagic myofasciitis
-
doi:10.1007/s11926-000-0079-6
-
Cherin P, Gherardi RK (2000) Macrophagic myofasciitis. Curr Rheumatol Rep 2:196-200. doi:10.1007/s11926-000-0079-6.
-
(2000)
Curr Rheumatol Rep
, vol.2
, pp. 196-200
-
-
Cherin, P.1
Gherardi, R.K.2
-
7
-
-
18644374381
-
Tacrolimus: In patients with rheumatoid arthritis
-
DOI 10.2165/00003495-200565070-00005
-
Curran MP, Perry CM (2005) Tacrolimus: in patients with rheumatoid arthritis. Drugs 65:993-1001. doi:10.2165/00003495-200565070-00005. (Pubitemid 40663623)
-
(2005)
Drugs
, vol.65
, Issue.7
, pp. 993-1001
-
-
Curran, M.P.1
Perry, C.M.2
-
8
-
-
0034623273
-
FK506 suppresses neutrophil chemoattractant production by peripheral blood mononuclear cells
-
doi:10.1016/S0014-2999(00)00592-6
-
Sasakawa Y, Sakuma S, Higashi Y, Sasakawa T, Amaya T, Goto T (2000) FK506 suppresses neutrophil chemoattractant production by peripheral blood mononuclear cells. Eur J Pharmacol 403:281-288. doi:10.1016/S0014-2999(00)00592- 6.
-
(2000)
Eur J Pharmacol
, vol.403
, pp. 281-288
-
-
Sasakawa, Y.1
Sakuma, S.2
Higashi, Y.3
Sasakawa, T.4
Amaya, T.5
Goto, T.6
-
9
-
-
33749591893
-
Successful treatment using tacrolimus (FK506) in a patient with TNF receptor-associated periodic syndrome (TRAPS) complicated by monocytic fasciitis [3]
-
DOI 10.1093/rheumatology/kel178
-
Ida H, Aramaki T, Arima K, Origuchi T, Kawakami A, Eguchi K (2006) Successful treatment using tacrolimus (FK506) in a patient with TNF receptor-associated periodic syndrome (TRAPS) complicated by monocytic fasciitis. Rheumatology 45:1171-1173. doi:10.1093/rheumatology/kel178. (Pubitemid 44542114)
-
(2006)
Rheumatology
, vol.45
, Issue.9
, pp. 1171-1173
-
-
Ida, H.1
Aramaki, T.2
Arima, K.3
Origuchi, T.4
Kawakami, A.5
Eguchi, K.6
|